[go: up one dir, main page]

SG11202105690TA - Ire1 small molecule inhibitors - Google Patents

Ire1 small molecule inhibitors

Info

Publication number
SG11202105690TA
SG11202105690TA SG11202105690TA SG11202105690TA SG11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA SG 11202105690T A SG11202105690T A SG 11202105690TA
Authority
SG
Singapore
Prior art keywords
small molecule
molecule inhibitors
ire1
ire1 small
inhibitors
Prior art date
Application number
SG11202105690TA
Inventor
Joseph P Vacca
Sarah Bettigole
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of SG11202105690TA publication Critical patent/SG11202105690TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11202105690TA 2018-12-03 2019-12-02 Ire1 small molecule inhibitors SG11202105690TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862774794P 2018-12-03 2018-12-03
PCT/US2019/063921 WO2020117635A1 (en) 2018-12-03 2019-12-02 Ire1 small molecule inhibitors

Publications (1)

Publication Number Publication Date
SG11202105690TA true SG11202105690TA (en) 2021-06-29

Family

ID=69024615

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105690TA SG11202105690TA (en) 2018-12-03 2019-12-02 Ire1 small molecule inhibitors

Country Status (8)

Country Link
US (1) US12071426B2 (en)
EP (1) EP3891137B1 (en)
JP (1) JP7546299B2 (en)
AU (1) AU2019393754A1 (en)
CA (1) CA3121755A1 (en)
IL (1) IL283433A (en)
SG (1) SG11202105690TA (en)
WO (1) WO2020117635A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI831829B (en) 2018-09-12 2024-02-11 美商建南德克公司 Phenoxy-pyridyl-pyrimidine compounds and methods of use
SG11202105690TA (en) 2018-12-03 2021-06-29 Univ Cornell Ire1 small molecule inhibitors
WO2020142612A1 (en) 2019-01-03 2020-07-09 Genentech, Inc. Pyrido-pyrimidinone and pteridinone compounds as inhibitors of endoribonuclease inositol requiring enzyme i (ire i alpha) for the treatment of cancer diseases.
WO2020172093A1 (en) * 2019-02-18 2020-08-27 Genentech, Inc. Pyrido-pyrimidinyl compounds and methods of use
WO2020232403A1 (en) * 2019-05-15 2020-11-19 Cornell University Treatment of fibrosis with ire1 small molecule inhibitors
CN114302877A (en) * 2019-06-11 2022-04-08 基因泰克公司 Quinazolinyl compounds and methods of use
US11840523B2 (en) * 2020-11-13 2023-12-12 The Regents Of The University Of California IRE1α inhibitors and uses thereof
US11912668B2 (en) 2020-11-18 2024-02-27 Deciphera Pharmaceuticals, Llc GCN2 and perk kinase inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8664230B2 (en) 2011-03-17 2014-03-04 The Asan Foundation Pyridopyrimidine derivatives and use thereof
WO2018102751A1 (en) 2016-12-02 2018-06-07 Quentis Therapeutics, Inc. Ire1 small molecule inhibitors
CN108239074B (en) * 2016-12-26 2021-07-06 中国医学科学院药物研究所 Quinazoline compound and its preparation method, use and pharmaceutical composition
AR111281A1 (en) 2017-03-17 2019-06-26 Genentech Inc PIRIMIDINIL-PIRIDILOXI-NAFTIL COMPOUNDS AND METHODS TO TREAT DISEASES AND DISORDERS RELATED TO IRE1
WO2018222918A1 (en) 2017-06-01 2018-12-06 Quentis Therapeutics, Inc. Ire1 small molecule inhibitors
EP3707126B1 (en) * 2017-11-10 2025-05-14 Cornell University Ire1 small molecule inhibitors
SG11202105690TA (en) 2018-12-03 2021-06-29 Univ Cornell Ire1 small molecule inhibitors

Also Published As

Publication number Publication date
US12071426B2 (en) 2024-08-27
JP7546299B2 (en) 2024-09-06
CA3121755A1 (en) 2020-06-11
JP2022511477A (en) 2022-01-31
AU2019393754A1 (en) 2021-07-22
IL283433A (en) 2021-07-29
EP3891137A1 (en) 2021-10-13
EP3891137B1 (en) 2024-10-09
US20220356168A1 (en) 2022-11-10
WO2020117635A1 (en) 2020-06-11

Similar Documents

Publication Publication Date Title
MA54543A (en) KIF18A INHIBITORS
MA54550A (en) KIF18A INHIBITORS
EP3843714A4 (en) CD73 INHIBITORS
IL283433A (en) Ire1 small molecule inhibitors
IL269196A (en) New inhibitors
MA52413A (en) CD73 INHIBITORS
EP3788042A4 (en) BCL-2 INHIBITORS
EP3630748A4 (en) SMALL MOLECULAR IRE1 INHIBITORS
DK3740479T3 (en) DNA-PK INHIBITORS
IL261557A (en) Small molecule ire1-alpha inhibitors
MA52812A (en) SARM1 INHIBITORS
EP3548476A4 (en) SMALL MOLECULAR IRE1 INHIBITORS
DK3571192T3 (en) JAK1-SELECTIVE INHIBITORS
EP3801499A4 (en) MRSA1 INHIBITORS
EP3817736A4 (en) PIKFYVE INHIBITORS
MA52813A (en) SARM1 INHIBITORS
SG11202010347XA (en) Stat3 inhibitors
DK3630744T3 (en) PYRAZOLE-MAGL INHIBITORS
EP3999517A4 (en) CD73 INHIBITORS
DK4051688T3 (en) CD73 INHIBITORS
MA50906A (en) IMMUNOPROTEASOME INHIBITORS
IL281949A (en) Small molecule menin inhibitors
MA49006A (en) IP6K INHIBITORS
EP3600301A4 (en) KDM4 INHIBITORS
IL276013A (en) Pi4kiiibeta inhibitors